Stephan Jackman's most recent trade in Alzamend Neuro Inc was a trade of 37,000 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on April 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alzamend Neuro Inc | Stephan Jackman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.54 per share. | 28 Apr 2023 | 37,000 | 45,500 | - | 0.5 | 19,999 | Common Stock |
| Alzamend Neuro Inc | Stephan Jackman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2022 | 2,000,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Alzamend Neuro Inc | Stephan Jackman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 19 Sep 2022 | 8,500 | 8,500 | - | 1.2 | 10,414 | Common Stock |